Literature DB >> 11054132

The level of serum lipids, vitamin E and low density lipoprotein oxidation in Wilson's disease patients.

M Rodo1, A Czonkowska, M Pulawska, M Swiderska, B Tarnacka, H Wehr.   

Abstract

UNLABELLED: The aim of this study was to estimate the level of lipids and of the main serum antioxidant, alpha-tocopherol (vitamin E), and to evaluate the susceptibility of low density lipoprotein (LDL) to oxidation in Wilson's disease patients. It was assumed that enhanced LDL peroxidation caused by high copper levels could contribute to the injury of liver and other tissues. The group investigated comprised 45 individuals with Wilson's disease treated with penicillamine or zinc salts and a control group of 36 healthy individuals. Lipids were determined by enzymatic methods, alpha-tocopherol by high performance liquid chromatography, the susceptibility of LDL to oxidation in vitro by absorption changes at 234 nm during 5 h and end-products of LDL lipid oxidation as thiobarbituric acid reacting substances. In Wilson's disease patients total cholesterol, LDL cholesterol and alpha-tocopherol levels were significantly lower compared with the control group. No difference in LDL oxidation in vitro between the patients and the controls was stated.
CONCLUSION: enhanced susceptibility of isolated LDL for lipid peroxidation in vitro was not observed in Wilson's disease patients. One cannot exclude, however, that because of low alpha-tocopherol level lipid peroxidation in the tissues can play a role in the pathogenesis of tissue injury in this disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054132     DOI: 10.1046/j.1468-1331.2000.t01-1-00115.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  6 in total

1.  Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms.

Authors:  Radan Bruha; Libor Vitek; Zdenek Marecek; Lenka Pospisilova; Sona Nevsimalova; Pavel Martasek; Jaromir Petrtyl; Petr Urbanek; Alena Jiraskova; Ivana Malikova; Martin Haluzik; Peter Ferenci
Journal:  J Inherit Metab Dis       Date:  2011-12-03       Impact factor: 4.982

2.  Reply.

Authors:  James Hamilton; Svetlana Lutsenko
Journal:  Hepatology       Date:  2016-12-24       Impact factor: 17.425

3.  Alterations of lipid metabolism in Wilson disease.

Authors:  Jessica Seessle; Annina Gohdes; Daniel Nils Gotthardt; Jan Pfeiffenberger; Nicola Eckert; Wolfgang Stremmel; Ulrike Reuner; Karl Heinz Weiss
Journal:  Lipids Health Dis       Date:  2011-05-19       Impact factor: 3.876

4.  Investigation of Dynamic Thiol/Disulfide Homeostasis and Nitrosative Stress in Patients with Wilson Disease.

Authors:  Emine Melis Yücel; Bugra Tolga Konduk; Ahmet Saracaloglu; Sezgin Barutçu; Seniz Demiryürek; Fatma Kaba; Belma Dogan Güngen; Abdullah Tuncay Demiryürek
Journal:  Turk J Gastroenterol       Date:  2021-09       Impact factor: 1.555

5.  A High-Calorie Diet Aggravates Mitochondrial Dysfunction and Triggers Severe Liver Damage in Wilson Disease Rats.

Authors:  Claudia Einer; Christin Leitzinger; Josef Lichtmannegger; Carola Eberhagen; Tamara Rieder; Sabine Borchard; Ralf Wimmer; Gerald Denk; Bastian Popper; Frauke Neff; Elena V Polishchuk; Roman S Polishchuk; Stefanie M Hauck; Christine von Toerne; Jennifer-Christin Müller; Uwe Karst; Bipin S Baral; Alan A DiSpirito; Andreas E Kremer; Jeremy Semrau; Karl Heinz Weiss; Simon Hohenester; Hans Zischka
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-12-23

6.  Novel ATPase Cu(2+) transporting beta polypeptide mutations in Chinese families with Wilson's disease.

Authors:  Shaojuan Gu; Huarong Yang; Yong Qi; Xiong Deng; Le Zhang; Yi Guo; Qing Huang; Jing Li; Xiaoliu Shi; Zhi Song; Hao Deng
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.